Markova, Alina

Publications

Sort by

Co-Author Network

selected publications

Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy. Journal for immunotherapy of cancer. 2024 Academic Article GET IT
Cutaneous Hypersensitivity Reactions to Immune Checkpoint Inhibitors. The journal of allergy and clinical immunology. In practice. 2024 Academic Article GET IT
Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies. Haematologica. 2024 Academic Article GET IT
Acute febrile neutrophilic dermatosis (Sweet syndrome) in acute myeloid leukemia patients: a 28-year institutional experience. Acta haematologica. 2023 Article GET IT
Safety of Immunomodulatory Systemic Therapies Used in the Management of Immune-Related Cutaneous Adverse Events. Pharmaceuticals (Basel, Switzerland). 2023 Review GET IT
Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients. Breast cancer research and treatment. 2023 Academic Article GET IT
Updates in SJS/TEN: collaboration, innovation, and community. Frontiers in medicine. 2023 Review GET IT
Times cited: 1
Management of immune-related cutaneous adverse events with dupilumab. Journal for immunotherapy of cancer. 2023 Academic Article GET IT
Development of a Skin-Directed Scoring System for Stevens-Johnson Syndrome and Epidermal Necrolysis: A Delphi Consensus Exercise. JAMA dermatology. 2023 Academic Article GET IT
Detection of novel therapies using a multi-national, multi-institutional registry of cutaneous immune-related adverse events and management. International journal of dermatology. 2023 Academic Article GET IT
PRO-CTCAE reveals under-recognition of dermatologic symptom burden in hospitalized cancer patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2023 Academic Article GET IT
Pruritus Related to Trastuzumab and Pertuzumab in HER2+ Breast Cancer Patients. 2023 GET IT
Times cited: 1219
Dermatologic complications in transplantation and cellular therapy for acute leukemia. Best practice & research. Clinical haematology. 2023 Review GET IT
A Review of Bullous Dermatologic Adverse Events Associated with Anti-Cancer Therapy. Biomedicines. 2023 Review GET IT
Times cited: 1
Efficacy of Immunotherapy with Combination of Cryotherapy and Topical Imiquimod for Treatment of Kaposi Sarcoma. Journal of medical virology. 2022 Letter GET IT
Dermatologic adverse events associated with IDH inhibitors ivosidenib and enasidenib for the treatment of acute myeloid leukemia. Leukemia research. 2022 Academic Article GET IT
Consensus on the clinical management of chronic radiation dermatitis and radiation fibrosis: a Delphi survey. The British journal of dermatology. 2022 Letter GET IT
Times cited: 4
Oncodermatology: Advancing the Science and Care of Cancer Patients and Survivors. American journal of clinical dermatology. 2022 Letter GET IT
High Grade Dermatologic Adverse Events Associated With Immune Checkpoint Blockade for Cancer. Frontiers in medicine. 2022 Review GET IT
Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma. Leukemia & lymphoma. 2022 Letter GET IT
Ibrutinib-associated dermatologic toxicities: A systematic review and meta-analysis. Critical reviews in oncology/hematology. 2022 Review GET IT
Phase 1/2 study of topical submicron particle paclitaxel for cutaneous metastases of breast cancer. Breast cancer research and treatment. 2022 Academic Article GET IT
Severe blistering eruptions induced by immune checkpoint inhibitors: a multicentre international study of 32 cases. Melanoma research. 2022 Academic Article GET IT
Times cited: 2
Telemedicine and Dermatology Hospital Consultations During The COVID-19 Pandemic: A Multi-Center Observational Study on Resource Utilization and Conversion to In-Person Consultations During the COVID-19 Pandemic. Journal of the European Academy of Dermatology and Venereology : JEADV. 2021 Letter GET IT
Patterns of the use of reflectance confocal microscopy at a tertiary referral dermatology clinic. Journal of the American Academy of Dermatology. 2021 Academic Article GET IT
Quality of Life Before and After Treatment of Cutaneous Metastases with Palliative Radiotherapy. Journal of the American Academy of Dermatology. 2021 Academic Article GET IT
Real-Time Reflectance Confocal Microscopy of Cutaneous Graft-versus-Host Disease Correlates with Histopathology. Transplantation and cellular therapy. 2021 Academic Article GET IT
ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia presenting in an infant: an entity distinct from JMML. Blood advances. 2021 Academic Article GET IT
Dermatologic infections in cancer patients treated with checkpoint inhibitors. Journal of the American Academy of Dermatology. 2021 Academic Article GET IT
Times cited: 2
Supporting Virtual Dermatology Consultation in the Setting of COVID-19. Journal of digital imaging. 2021 Editorial Article GET IT
IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies. Annals of oncology : official journal of the European Society for Medical Oncology. 2021 Academic Article GET IT
Times cited: 2
Treatment of severe cutaneous adverse reaction with tocilizumab. The British journal of dermatology. 2020 Article GET IT
Times cited: 9
Use of teledermatology by dermatology hospitalists is effective in the diagnosis and management of inpatient disease. Journal of the American Academy of Dermatology. 2020 Academic Article GET IT
Times cited: 20
Association of interleukin-6 and tumor necrosis factor-α with mortality in hospitalized patients with cancer. Journal of the American Academy of Dermatology. 2020 Academic Article GET IT
Times cited: 6
Outpatient dermatology consultations for oncology patients with acute dermatologic adverse events impact anticancer therapy interruption: a retrospective study. Journal of the European Academy of Dermatology and Venereology : JEADV. 2020 Academic Article GET IT
Times cited: 26
Drugs as a Frequent Cause of Acute Rash in Patients after CD34⁺-Selected Peripheral Blood Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Academic Article GET IT
Times cited: 3
Treatment Outcomes of Immune-Related Cutaneous Adverse Events. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 Academic Article GET IT
Times cited: 164
Dermatology-specific and all-cause 30-day and calendar-year readmissions and costs for dermatologic diseases from 2010 to 2014. Journal of the American Academy of Dermatology. 2019 Academic Article GET IT
Times cited: 18
Markers of systemic involvement and death in hospitalized cancer patients with severe cutaneous adverse reactions. Journal of the American Academy of Dermatology. 2018 Academic Article GET IT
Times cited: 9
Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients. Journal of the American Academy of Dermatology. 2017 Academic Article GET IT
Times cited: 23
A review of hand-held, home-use cosmetic laser and light devices. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 2015 Information Resource GET IT
Times cited: 17
Effect of a web-based curriculum on primary care practice: basic skin cancer triage trial. Family medicine. 2013 Academic Article GET IT
Times cited: 10
Risk of skin cancer associated with the use of UV nail lamp. The Journal of investigative dermatology. 2012 Article GET IT
Times cited: 22
Correlation between BRAF mutation and promoter methylation of TIMP3, RARβ2 and RASSF1A in thyroid cancer. Epigenetics. 2012 Academic Article GET IT
Times cited: 57
Models of care and organization of services. Dermatologic clinics. 2012 Information Resource GET IT
US skin disease assessment: ulcer and wound care. Dermatologic clinics. 2012 Information Resource GET IT
Times cited: 79

more ...

less ...

Background

education and training

M.D., Brown University School of Medicine 2012
B.A., The Johns Hopkins University 2008

Contact

full name

Alina Markova

primary email

alm2804@med.cornell.edu

VIVO Weill Cornell Medical College

Alina Markova Assistant Professor of Dermatology

Publications

selected publications

Background

education and training

Contact

full name

primary email